NO920523L - Ige-reseptor-antistoff - Google Patents

Ige-reseptor-antistoff

Info

Publication number
NO920523L
NO920523L NO92920523A NO920523A NO920523L NO 920523 L NO920523 L NO 920523L NO 92920523 A NO92920523 A NO 92920523A NO 920523 A NO920523 A NO 920523A NO 920523 L NO920523 L NO 920523L
Authority
NO
Norway
Prior art keywords
ige
receptor antibody
antibody
receptor
Prior art date
Application number
NO92920523A
Other languages
English (en)
Norwegian (no)
Other versions
NO920523D0 (no
Inventor
Richard Anthony Chizzonite
John Hakimi
Jarema Peter Kochan
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO920523D0 publication Critical patent/NO920523D0/no
Publication of NO920523L publication Critical patent/NO920523L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO92920523A 1991-02-11 1992-02-10 Ige-reseptor-antistoff NO920523L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65393691A 1991-02-11 1991-02-11

Publications (2)

Publication Number Publication Date
NO920523D0 NO920523D0 (no) 1992-02-10
NO920523L true NO920523L (no) 1992-08-12

Family

ID=24622869

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920523A NO920523L (no) 1991-02-11 1992-02-10 Ige-reseptor-antistoff

Country Status (20)

Country Link
EP (1) EP0499112A1 (cs)
JP (1) JPH05252988A (cs)
KR (1) KR920016105A (cs)
AR (1) AR245784A1 (cs)
AU (1) AU652024B2 (cs)
BR (1) BR9200442A (cs)
CA (1) CA2059842A1 (cs)
CS (1) CS39092A3 (cs)
FI (1) FI920565L (cs)
HU (1) HUT63205A (cs)
IE (1) IE920434A1 (cs)
IL (1) IL100869A0 (cs)
IS (1) IS3813A (cs)
MX (1) MX9200526A (cs)
NO (1) NO920523L (cs)
NZ (1) NZ241552A (cs)
RO (1) RO109707B1 (cs)
UY (1) UY23374A1 (cs)
YU (1) YU13392A (cs)
ZA (1) ZA92800B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770396A (en) * 1992-04-16 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
EP0733207B1 (en) * 1993-12-10 1997-08-27 Genentech, Inc. Methods for diagnosis of allergy and screening of anti-allergy therapeutics
JP2952750B2 (ja) * 1995-02-23 1999-09-27 株式会社林原生物化学研究所 モノクローナル抗体
US7135458B1 (en) 1995-11-15 2006-11-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
US6423512B1 (en) 1996-07-26 2002-07-23 Novartis Ag Fusion polypeptides
AR008077A1 (es) * 1996-07-26 1999-12-09 Talarico Salinas Laura Beatriz Un polipeptido de fusion o una sal del mismo, su uso, un proceso para prepararlos, una composicion farmaceutica que los comprende, y un vector.
US6299875B1 (en) 1998-06-04 2001-10-09 Panacea Pharmaceuticals, Llc Methods to block IGE binding to cell surface receptors of mast cells
US7759133B2 (en) 1998-12-22 2010-07-20 Alk-Abello A/S Method of detecting and/or quantifying a specific IgE antibody in a liquid sample
EP1269198A2 (en) * 2000-03-23 2003-01-02 Novartis AG Identification of mast/basophil activation inhibitors
KR100932465B1 (ko) 2001-07-19 2009-12-17 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 인간형 항인간 IgE 수용체 항체 및 항체 단편
EP2115139B8 (en) * 2007-01-29 2015-03-18 Teknologian tutkimuskeskus VTT Oy Method for producing novel ige based reagents
KR101686395B1 (ko) 2015-06-22 2016-12-15 주식회사 선일기연 Pcb용 단자 삽입기의 삽입력 측정장치
CN105352930A (zh) * 2015-12-01 2016-02-24 深圳市绿诗源生物技术有限公司 基于amf为荧光素标记物的双酚a荧光偏振免疫分析检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962035A (en) * 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof

Also Published As

Publication number Publication date
CA2059842A1 (en) 1992-08-12
HU9200293D0 (en) 1992-04-28
AU652024B2 (en) 1994-08-11
HUT63205A (en) 1993-07-28
YU13392A (sh) 1995-01-31
KR920016105A (ko) 1992-09-24
UY23374A1 (es) 1992-07-30
IE920434A1 (en) 1992-08-12
ZA92800B (en) 1992-10-28
FI920565A0 (fi) 1992-02-11
NZ241552A (en) 1994-03-25
IS3813A (is) 1992-08-12
CS39092A3 (en) 1992-09-16
FI920565A7 (fi) 1992-08-12
FI920565L (fi) 1992-08-12
AU1080292A (en) 1992-08-13
RO109707B1 (ro) 1995-05-30
JPH05252988A (ja) 1993-10-05
AR245784A1 (es) 1994-02-28
BR9200442A (pt) 1992-10-20
MX9200526A (es) 1992-08-01
IL100869A0 (en) 1992-11-15
EP0499112A1 (en) 1992-08-19
NO920523D0 (no) 1992-02-10

Similar Documents

Publication Publication Date Title
FI930580L (fi) Tri- och tetravalensiska monopecifika antigen bindande proteiner
DE69225757D1 (de) Lyophilische monoklonale antikörperpräparationen
DK145493D0 (da) Antistof
DK666389A (da) Monoklonalt antistof
DE69232604D1 (de) Antikörperkonstrukte
CY2006001I2 (el) Ανθρωποποιημενο heregulin αντισωμα
DK0574782T3 (da) Dobbeltanalyt-immunassay
FI933328L (fi) Antigen producerande protein
FI940144A7 (fi) Vasta-aineiden tuotanto
FI930846A7 (fi) Homokonjugoituja immunoglobuliineja
DE68914244D1 (de) Monoklonaler Antikörper.
FI935970L (fi) Tumoer/kolhydratantigenspecifik monoklonal antikropp samt cellinje
NO920523D0 (no) Ige-reseptor-antistoff
EP0580859A4 (en) Anti-eda monoclonal antibody
FI895287A7 (fi) Fukosyylikeramidin vastainen monoklonaalinen vasta-aine
FI922681L (fi) Nytt foerpacknings/behaollarsystem
DE69223606D1 (de) Humaner monoklonaler antikörper gegen glycoprotein-iib/iiia
FI934447A0 (fi) Nytt immunhaemmande aemne fraon strptomyces braegensis
FI945485L (fi) Monoklonaaliset vasta-aineet ja niiden käyttö
FI922683L (fi) Nytt foerpacknings/behaollarsystem
DK474189A (da) Monoklonalt antistof
ITMI910491A0 (it) Immonotossina da anticorpi monoclonali anti-cds
FI922682L (fi) Nytt foerpacknings/behaollarsystem
DK413389D0 (da) Monoklonale antistoffer
DE69427850D1 (de) Monoklonaler antikörper gegen mucoglykoprotein